Anti-TAG-72 / CA72.4 (Tumor-Associated Glycoprotein)(Clone: CA72/145)

Anti-TAG-72 / CA72.4 (Tumor-Associated Glycoprotein)(Clone: CA72/145)
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
ABE-36-1094-100 100 µg -

3 - 11 Werktage*

853,00 €
 
Recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72)... mehr
Produktinformationen "Anti-TAG-72 / CA72.4 (Tumor-Associated Glycoprotein)(Clone: CA72/145)"
Recognizes an oncofetal antigen of 220kDa, identified as a tumor-associated glycoprotein (TAG-72) with properties of a mucin. The majority of human adenocarcinomas including colorectal, pancreatic, gastric, ovarian, endometrial, mammary, and non-small cell lung cancer display some cell populations that are positive for TAG72. About 60% of carcinoma patients express TAG72 in their sera. TAG72 is reportedly useful in distinguishing pulmonary adenocarcinomas from pleural mesotheliomas. Protein function: mRNA-capping methyltransferase that methylates the N7 position of the added guanosine to the 5'-cap structure of mRNAs. Binds RNA containing 5'-terminal GpppC. [The UniProt Consortium]
Schlagworte: Anti-tag-72, Anti-C25A1.3, Anti-mRNA cap guanine-N7 methyltransferase, Anti-mRNA (guanine-N(7)-)-methyltransferase, Monoclonal Antibody to TAG-72 / CA72.4 (Tumor-Associated Glycoprotein)(Clone: CA72/145)
Hersteller: Abeomics
Hersteller-Nr: 36-1094

Eigenschaften

Anwendung: IP, FC, WB, IF
Antikörper-Typ: Monoclonal
Klon: CA72/145
Konjugat: No
Wirt: Mouse
Spezies-Reaktivität: human
Immunogen: Human CA72.4 protein
Format: Affinity Purified

Handhabung & Sicherheit

Lagerung: +4°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-TAG-72 / CA72.4 (Tumor-Associated Glycoprotein)(Clone: CA72/145)"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen